Re-link HCV in Substance-Use Telemedicine Program - Trial NCT06349902
Access comprehensive clinical trial information for NCT06349902 through Pure Global AI's free database. This phase not specified trial is sponsored by trueNorth Medical Centres and is currently Recruiting. The study focuses on Hepatitis C. Target enrollment is 5000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
trueNorth Medical Centres
Timeline & Enrollment
N/A
Mar 12, 2024
Dec 31, 2024
Primary Outcome
number of patients identified as having diagnosed but untreated HCV,percentage of patients identified as having diagnosed but untreated HCV that are re-linked to HCV care
Summary
This is an observational, retrospective & prospective cohort study. The retrospective element
 of the study is a chart review to identify people with diagnosed but untreated HCV and
 re-link them to care. The observational prospective cohort element of the study will examine
 the HCV linkage to care, treatment initiation, treatment completion & cure rates of these HCV
 clients achieved through this chart review and re-linking approach.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06349902
Non-Device Trial